EUVIMEDEUVIMED entdecken
Crossref

Affinity-based selection of anti-Feline Leukaemia Virus p27 monoclonal antibodies for efficient lateral flow assay development

Hadyn Duncan, Elisabeth Domingo-Contreras, Sotirios Athanasiou, Rosario Fernandez-Godino, Francisco Castillo, Ana Camacho

Analytical Biochemistry · 2026-02 · 709 · 116013

DOI: 10.1016/j.ab.2025.116013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Biochemistry, 2026-02. Verfasst von Hadyn Duncan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rekom Biotech S.L., BIC Granada, Avda. de la Innovación 1, 18016, Granada, Spain. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Antibodies, Viral. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional diagnostic methods like RT-PCR and proviral DNA PCR have limitations, underscoring the need for swift, sensitive alternatives such as lateral flow immunoassays (LFIA). Yet, efficiently identifying monoclonal antibody (mAb) pairs for robust ternary antigen-antibody interactions remains a universal bottleneck, as conventional ELISA screening is costly and may not accurately reflect native binding. Here, we combined ELISA with Spectral Shift Technology (SST) to minimise reagent use and comprehensively profile anti-FeLV p27 mAbs. This orthogonal approach enabled rapid selection of two low nanomolar mAbs with different epitope targets that form a ternary complex, which translates into a sensitive detection of the FeLV p27 in a LFIA prototype. Our screening methodology supports resource-efficient LFIA development for FeLV and extends to other significant animal and human pathogens like Monkeypox or Helicobacter pylori, improving diagnostics and quality control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalAntibodies, ViralEnzyme-Linked Immunosorbent AssayHumansAnimalsAntibody Affinity

Stichwörter der Autor:innen

AffinityAntigen-antibody interactionLateral flow assay developmentMonoclonal antibody screeningTernary complexes

Substanzen

Antibodies, MonoclonalAntibodies, Viral

Autor:innen und Institutionen

  • Rekom Biotech S.L., BIC Granada, Avda. de la Innovación 1, 18016, Granada, Spain.
  • Fundación MEDINA, Parque Tecnológico de Ciencias de la Salud, Avda. del Conocimiento 34, 18016, Granada, Spain.
  • Uranovet S.L., Av. Santa Eulalia 2, Les Franqueses, 08520, Barcelona, Spain.
  • Fundación MEDINA, Parque Tecnológico de Ciencias de la Salud, Avda. del Conocimiento 34, 18016, Granada, Spain. Electronic address: francisco.castillo@medinaandalucia.es.
  • Rekom Biotech S.L., BIC Granada, Avda. de la Innovación 1, 18016, Granada, Spain. Electronic address: agcamacho@rekombiotech.com.

Zitieren

APA

Duncan, H., Domingo-Contreras, E., Athanasiou, S., Fernandez-Godino, R., Castillo, F., & Camacho, A. (2026). Affinity-based selection of anti-Feline Leukaemia Virus p27 monoclonal antibodies for efficient lateral flow assay development. Analytical Biochemistry, 709, 116013. https://doi.org/10.1016/j.ab.2025.116013

Vancouver

Duncan H, Domingo-Contreras E, Athanasiou S, Fernandez-Godino R, Castillo F, Camacho A. Affinity-based selection of anti-Feline Leukaemia Virus p27 monoclonal antibodies for efficient lateral flow assay development. Analytical Biochemistry. 2026;709:116013. doi:10.1016/j.ab.2025.116013

BibTeX
@article{Duncan2026,
  author = {Duncan, Hadyn and Domingo-Contreras, Elisabeth and Athanasiou, Sotirios and Fernandez-Godino, Rosario and Castillo, Francisco and Camacho, Ana},
  title = {Affinity-based selection of anti-Feline Leukaemia Virus p27 monoclonal antibodies for efficient lateral flow assay development},
  journal = {Analytical Biochemistry},
  year = {2026},
  volume = {709},
  pages = {116013},
  doi = {10.1016/j.ab.2025.116013}
}
Kostenlos starten →